Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03927352
Brief Title: The Purpose of This Research Study is to Compare the Efficacy and Safety of SCT630 and Adalimumab (HUMIRA®) in Adults With Plaque Psoriasis

First Submitted : April 22, 2019
First Submitted that Met QC Criteria : April 24, 2019
First Posted : April 25, 2019

Last Update Submitted that Met QC Criteria : April 24, 2019
Last Update Posted : April 25, 2019